ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

91.06 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	134
Open	91.06
Bid (Size)	89.86 (100)
Ask (Size)	92.00 (100)
Prev. Close	91.06
Today's Range	91.06 - 91.06
52wk Range	54.11 - 92.59
Shares Outstanding	384,800,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Dexcom (NASDAQ:DXCM) Combines Strong Growth With a Bullish Technical Setup ↗

August 20, 2026

Via Chartmill

1 Healthcare Stock to Target This Week and 2 Facing Headwinds

August 20, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...

Via StockStory

Performance

YTD	+36.9%	+36.9%
1 Month	+24.1%	+24.1%
3 Month	+26.5%	+26.5%
6 Month	+24.3%	+24.3%
1 Year	+19.9%	+19.9%

More News

1 Surging Stock Worth Your Attention and 2 We Question

August 14, 2026

Via StockStory

1 Growth Stock to Stash and 2 We Brush Off

August 13, 2026

Via StockStory

1 S&P 500 Stock on Our Buy List and 2 We Avoid

August 12, 2026

Via StockStory

DexCom (NASDAQ:DXCM) Stands Out as an Affordable Growth Stock ↗

August 04, 2026

Via Chartmill

Dexcom (NASDAQ:DXCM) Beats Q2 Earnings Estimates, Raises Profitability Guidance ↗

July 30, 2026

Via Chartmill

5 Insightful Analyst Questions From DexCom’s Q2 Earnings Call

August 06, 2026

Via StockStory

Wednesday's session: top gainers and losers in the S&P500 index ↗

August 05, 2026

Via Chartmill

DexCom (DXCM) Q2 2026 Earnings Call Transcript ↗

August 03, 2026

Via The Motley Fool

Stay informed with the top movers within the S&P500 index on Friday. ↗

July 31, 2026

Via Chartmill

Friday's session: top gainers and losers in the S&P500 index ↗

July 31, 2026

Via Chartmill

Why Is DexCom (DXCM) Stock Rocketing Higher Today

July 31, 2026

Via StockStory

These S&P500 stocks are gapping in today's session ↗

July 31, 2026

Via Chartmill

Get insights into the top movers in the S&P500 index of Friday's pre-market session. ↗

July 31, 2026

Via Chartmill

DXCM Q2 Deep Dive: Expanded Access and Product Updates Drive Growth

July 31, 2026

Via StockStory

DexCom (DXCM) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Via The Motley Fool

DexCom Q2 Earnings Call Highlights ↗

July 30, 2026

Via MarketBeat

Which S&P500 stocks are moving after the closing bell on Thursday? ↗

July 30, 2026

Via Chartmill

DexCom’s (NASDAQ:DXCM) Q2 CY2026 Sales Beat Estimates

July 30, 2026

Via StockStory

Dexcom Reports Second Quarter 2026 Financial Results

July 30, 2026

From DexCom, Inc.

Via Business Wire

3 Beaten-Down Stocks With GLP-1 Exposure to Buy and Hold ↗

July 29, 2026

Via The Motley Fool

DexCom Earnings: What To Look For From DXCM

July 28, 2026

Via StockStory

Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the Firm

July 23, 2026

From Kaskela Law LLC

Via Business Wire

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

July 22, 2026

From DexCom, Inc.

Via Business Wire

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?

Yes, DexCom, Inc. - Common Stock is publicly traded.

What exchange does DexCom, Inc. - Common Stock trade on?

DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DexCom, Inc. - Common Stock?

The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market

What is the current price of DexCom, Inc. - Common Stock?

The current price of DexCom, Inc. - Common Stock is 91.06

When was DexCom, Inc. - Common Stock last traded?

The last trade of DexCom, Inc. - Common Stock was at 08/24/26 04:00 PM ET

What is the market capitalization of DexCom, Inc. - Common Stock?

The market capitalization of DexCom, Inc. - Common Stock is 35.04B

How many shares of DexCom, Inc. - Common Stock are outstanding?

DexCom, Inc. - Common Stock has 35B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.